ITUA20162896A1 - NUTRACEUTICAL COMPOUND FOR THE TREATMENT OF EXCESS OF URIC ACID - Google Patents

NUTRACEUTICAL COMPOUND FOR THE TREATMENT OF EXCESS OF URIC ACID

Info

Publication number
ITUA20162896A1
ITUA20162896A1 ITUA2016A002896A ITUA20162896A ITUA20162896A1 IT UA20162896 A1 ITUA20162896 A1 IT UA20162896A1 IT UA2016A002896 A ITUA2016A002896 A IT UA2016A002896A IT UA20162896 A ITUA20162896 A IT UA20162896A IT UA20162896 A1 ITUA20162896 A1 IT UA20162896A1
Authority
IT
Italy
Prior art keywords
excess
treatment
uric acid
nutraceutical compound
nutraceutical
Prior art date
Application number
ITUA2016A002896A
Other languages
Italian (it)
Inventor
Vincenzo Maglione
Original Assignee
Akademy Pharma S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akademy Pharma S R L filed Critical Akademy Pharma S R L
Priority to ITUA2016A002896A priority Critical patent/ITUA20162896A1/en
Publication of ITUA20162896A1 publication Critical patent/ITUA20162896A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
ITUA2016A002896A 2016-04-26 2016-04-26 NUTRACEUTICAL COMPOUND FOR THE TREATMENT OF EXCESS OF URIC ACID ITUA20162896A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITUA2016A002896A ITUA20162896A1 (en) 2016-04-26 2016-04-26 NUTRACEUTICAL COMPOUND FOR THE TREATMENT OF EXCESS OF URIC ACID

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A002896A ITUA20162896A1 (en) 2016-04-26 2016-04-26 NUTRACEUTICAL COMPOUND FOR THE TREATMENT OF EXCESS OF URIC ACID

Publications (1)

Publication Number Publication Date
ITUA20162896A1 true ITUA20162896A1 (en) 2017-10-26

Family

ID=56684162

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A002896A ITUA20162896A1 (en) 2016-04-26 2016-04-26 NUTRACEUTICAL COMPOUND FOR THE TREATMENT OF EXCESS OF URIC ACID

Country Status (1)

Country Link
IT (1) ITUA20162896A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3025593A1 (en) * 2014-11-28 2016-06-01 Akademy Pharma S.r.l. Nutraceutical compound for the treatment of excess weight and moderate hypercholesterolemia/dysglycemia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3025593A1 (en) * 2014-11-28 2016-06-01 Akademy Pharma S.r.l. Nutraceutical compound for the treatment of excess weight and moderate hypercholesterolemia/dysglycemia

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Guarda dentro una compressa e scopri cosa c'è | LopiGLIK", 19 December 2016 (2016-12-19), XP055330122, Retrieved from the Internet <URL:http://www.lopiglik.it/lopiglik/guarda-dentro-una-compressa.xhtml> [retrieved on 20161219] *
FRANCESCO ROZZA ET AL: "Effects of a Novel Fixed Combination of Nutraceuticals on Serum Uric Acid Concentrations and the Lipid Profile in Asymptomatic Hyperuricemic Patients", HIGH BLOOD PRESSURE AND CARDIOVASCULAR PREVENTION, 19 September 2016 (2016-09-19), IT, XP055330075, ISSN: 1120-9879, DOI: 10.1007/s40292-016-0168-x *
HUI DONG ET AL: "The Effects of Berberine on Blood Lipids: A Systemic Review and Meta-Analysis of Randomized Controlled Trials", PLANTA MEDICA, vol. 79, no. 06, 18 April 2013 (2013-04-18), DE, pages 437 - 446, XP055330108, ISSN: 0032-0943, DOI: 10.1055/s-0032-1328321 *
S. K. PANCHAL ET AL: "Rutin Attenuates Metabolic Changes, Nonalcoholic Steatohepatitis, and Cardiovascular Remodeling in High-Carbohydrate, High-Fat Diet-Fed Rats", THE JOURNAL OF NUTRITION, vol. 141, no. 6, 1 June 2011 (2011-06-01), US, pages 1062 - 1069, XP055330127, ISSN: 0022-3166, DOI: 10.3945/jn.111.137877 *
VALENTINA TRIMARCO ET AL: "Effects of a New Combination of Nutraceuticals with Morus alba on Lipid Profile, Insulin Sensitivity and Endotelial Function in Dyslipidemic Subjects. A Cross-Over, Randomized, Double-Blind Trial", HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, vol. 22, no. 2, 14 April 2015 (2015-04-14), pages 149 - 154, XP055206369, ISSN: 1120-9879, DOI: 10.1007/s40292-015-0087-2 *
VERONIQUE VERHOEVEN ET AL: "Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial", BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, BIOMED CENTRAL LTD., LONDON, GB, vol. 13, no. 1, 18 July 2013 (2013-07-18), pages 178, XP021156586, ISSN: 1472-6882, DOI: 10.1186/1472-6882-13-178 *

Similar Documents

Publication Publication Date Title
DK3383363T3 (en) Topical pharmaceutical formulations for the treatment of inflammatory-related conditions
IT201700081449A1 (en) PURIFICATION PROCEDURE OF HYALURONIC ACID
MA41200B1 (en) Process for the preparation of a diarylthiohydantoin compound
IL286592A (en) Amino acid compositions for the treatment of liver disease
DK3498278T3 (en) Compounds for the treatment of diseases related to DUX4 expression
IL283837A (en) Augmented acid alpha-glucosidase for the treatment of pompe disease
IT201600097392A1 (en) Method for the preparation of 3-fluoroalkyl-1-methylpyrazole-4-carboxylic acid
HK1250717A1 (en) Processes for the preparation of galnac acid derivatives
DE102016003950A8 (en) Machine train for the production of nitric acid
ITUA20161550A1 (en) Procedure for the production of RNA
ITUB20160121A1 (en) GABAPENTIN OFTALMIC FOR THE TREATMENT OF CORNEAL ULCERS
ITUA20162896A1 (en) NUTRACEUTICAL COMPOUND FOR THE TREATMENT OF EXCESS OF URIC ACID
IT201900025186A1 (en) Method for the purification of cysteamine
SG11202103001PA (en) Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application
IT201700057247A1 (en) KELANIC AGENTS FOR THE TREATMENT OF NUTRITIONAL DISORDERS OF PLANTS
ITMI20131652A1 (en) PROCEDURE FOR THE PURIFICATION OF DERIVATIVES OF 2-PHENYL-2-METHYL-PROPANOIC ACID
HK1253014A1 (en) Augmented acid alpha-glucosidase for the treatment of pompe disease
IT201700031017A1 (en) Compositions useful for the treatment of androgenic alopecia comprising etidronic acid
IT201700108102A1 (en) COMPOSITION OF BACTERICIDAL / PERMEABILITY INCREASING PROTEIN AND HYALURONIC ACID FOR THE TREATMENT OF ARTROPATHIES
IT201700123558A1 (en) PROCESS FOR THE SYNTHESIS OF 2-BENZIDRIL-3 KINUCLIDINONE
DK3533791T3 (en) Process for the preparation of 3-methyl-2-thiophenecarboxylic acid
ITUA20163066A1 (en) COMPOSITION FOR THE TREATMENT OF DEPENDENCIES
IT201600130064A1 (en) COMPOSITIONS FOR THE TREATMENT OF SKIN INJURIES
GB201705480D0 (en) Medicine intermediates sulfanilic acid synthesis method
IT201600129605A1 (en) COMPOSITION FOR THE TREATMENT OF MUSCLE-SKELETAL PATHOLOGIES